Skip to content

Yoga and cardiovascular health trial

Yoga And Cardiovascular Health Trial (YACHT): a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12924088
Enrollment
80
Registered
2018-03-05
Start date
2012-10-03
Completion date
Unknown
Last updated
2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Referred to cardiac rehabilitation programmes post- angioplasty, coronary artery bypass grafting or prescribed medical management only as treatment for an acute coronary syndrome Circulatory System Acute ischaemic heart disease, unspecified

Interventions

The acute study compared cardiovascular measures pre and post the first bout of yoga in participants randomised to the yoga arm only, the chronic study compared cardiovascular measures at 3 months bet

Sponsors

Imperial College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Referred to cardiac rehabilitation programmes post- angioplasty, coronary artery bypass grafting or prescribed medical management only as treatment for an acute coronary syndrome 2. Age 35-80

Exclusion criteria

Exclusion criteria: 1. Co-morbid disease or mobility limitations that would preclude participation in cardiac rehabilitation, yoga or study investigations 2. Unable to understand either English or Punjabi

Design outcomes

Primary

MeasureTime frame
Acute study: Brachial blood pressure recovery after the Dundee 3-minute step test, measured on the day of the first yoga session, before and after the first yoga session. For each set of readings, blood pressure and heart rate are measured using an OMRON oscillometric device before the step test, immediately after the step test and then at 3 minutes after the step test Chronic study: 1. Left ventricular diastolic function, measured using echocardiography at baseline and at three months follow-up. The ratio of early filling to early myocardial velocity (E/e’) is used to estimate left ventricular diastolic function 2. 24 hour ambulatory blood pressure, measured using a Mobilograph oscillometric cuff-based device at baseline and at three months follow-up

Secondary

MeasureTime frame
Acute study: 1. Salivary cortisol as a measure of the hypothalamic-pituitary axis, measured from consecutive saliva samples taken by the participant using the Salivette self collection system on 5 occasions on the day of the first yoga session 2. Salivary alpha amylase as a measure of autonomic function measured from consecutive saliva samples taken by the participant using the Salivette system on 5 occasions on the day of the first yoga session Chronic study: 1. Brachial blood pressure recovery after the Dundee 3-minute step test, measured at baseline and at three months follow-up. For each set of readings, blood pressure and heart rate are measured using an OMRON oscillometric device before the step test, immediately after the step test and then at 3 minutes after the step test 2. Resting blood pressure, measured using a Pulsecor (applanation tonometry) device at baseline and three months follow-up 3. Central blood pressure, measured using a Pulsecor device at baseline and three months follow-up 4. Pulse wave velocity, measured using a Vicorder oscillometric device at baseline and three months follow-up 5. Salivary cortisol as a measure of the hypothalamic-pituitary axis, measured from consecutive saliva samples taken by the participant using the Salivette system on 5 occasions on one day at baseline and on one day at three months follow-up 6. Glucose, total and LDL cholesterol, measured from venous blood samples at baseline and three months follow-up 7. Anthropometric measures to assess obesity at baseline and three months follow-up 8. Body fat percent, measured using a Tanita bioimpedance device at baseline and three months follow-up 9. Autonomic function: heart rate variability and baroreflex sensitivity measured at baseline and three months follow-up. Beat to beat arte

Countries

England, United Kingdom

Contacts

Public ContactTherese Tillin

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026